XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Cash flows from operating activities from continuing operations    
Net loss $ (9,588) $ (23,514)
Loss from discontinued operations, net of income taxes (7,805)
Net loss from continuing operations, net of tax (9,588) (15,709)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:    
Stock-based compensation expense 1,341 270
Non-cash interest expense 1,008 1,248
Non-cash lease expense 181 248
Depreciation and amortization 357 189
Provision for credit losses 62 2,117
Change in reserve for excess and obsolete inventory (344) 791
Change in fair value of forward purchase agreement liabilities 5,578
Change in fair value of warrant liabilities (7,246) (209)
Accretion of debt in CS Solis 2,560 752
Changes in operating assets and liabilities:    
Accounts receivable, net 5,280 (3,197)
Inventories 629 (570)
Prepaid expenses and other current assets 41 (1,857)
Other noncurrent assets (848)
Accounts payable (2,599) 2,132
Accrued expenses and other current liabilities (1,613) (581)
Operating lease liabilities (180) (86)
Warranty provision, noncurrent 100
Deferred revenue (413) (906)
Net cash used in operating activities from continuing operations (4,946) (16,116)
Net cash used in operating activities from discontinued operations (162)
Net cash used in operating activities (4,946) (16,278)
Cash flows from investing activities from continuing operations    
Purchase of property and equipment (30)
Capitalization of internal-use software costs (536) (457)
Proceeds from sale of property and equipment 1
Net cash used in investing activities from continuing operations (536) (486)
Cash flows from financing activities from continuing operations    
Proceeds from issuance of notes payable, net 14,102
Principal repayment of notes payable (300) (9,603)
Proceeds from issuance of convertible notes, net of issuance cost 11,000
Proceeds from exercise of common stock options 26 55
Proceeds from issuance of SAFE agreements 5,000
Net cash provided by financing activities from continuing operations 4,726 15,554
Effect of exchange rate changes (45) 1
Net decrease in cash, cash equivalents and restricted cash (801) (1,209)
Cash, cash equivalents, and restricted cash at beginning of period 6,416 8,316
Cash, cash equivalents, and restricted cash at end of period 5,615 7,107
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest $ 1,608